Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
Foote
J E
JE
Division of Urology, University of Colorado Health Sciences Center, Denver 80262.
Crawford
E D
ED
D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007016:Hypophysectomy; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D011897:Random Allocation
D000726:Androgen Antagonists